The PE Ratio as of November 2024 (TTM) for Pasithea Therapeutics Corp. (KTTA) is -0.21

According to Pasithea Therapeutics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.21. This represents a change of -31.40% compared to the average of -0.31 of the last 4 quarters.

Pasithea Therapeutics Corp. (KTTA) Historical PE Ratio (quarterly & annually)

How has KTTA PE Ratio performed in the past?

The mean historical PE Ratio of Pasithea Therapeutics Corp. over the last ten years is -304.35. The current -0.21 PE Ratio has changed -93.10% with respect to the historical average. Over the past ten years (40 quarters), KTTA's PE Ratio was at its highest in in the March 2022 quarter at 3.62K. The PE Ratio was at its lowest in in the September 2020 quarter at -16638.44.

Pasithea Therapeutics Corp. (KTTA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pasithea Therapeutics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pasithea Therapeutics Corp. (KTTA) Average PE Ratio

How has KTTA PE Ratio performed in the past?

The current PE Ratio of Pasithea Therapeutics Corp. (KTTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pasithea Therapeutics Corp. (KTTA) PE Ratio vs. Peers

How is KTTA’s PE Ratio compared to its peers?

Pasithea Therapeutics Corp.’s PE Ratio is greater than Nutriband Inc. (-7.34), greater than ZIVO Bioscience, Inc. (-5.20), less than MediciNova, Inc. (-0.04), greater than Eliem Therapeutics, Inc. (-2.42), greater than Virax Biolabs Group Limited (-0.67), greater than Blue Water Vaccines, Inc. (-0.26), less than Revelation Biosciences, Inc. (-0.13), greater than Hillstream BioPharma, Inc. (-0.99), less than Kiora Pharmaceuticals, Inc. (2.56), greater than Kezar Life Sciences, Inc. (-5.71), greater than Kronos Bio, Inc. (-0.64), greater than Quoin Pharmaceuticals, Ltd. (-0.33), greater than RenovoRx, Inc. (-3.51), greater than ABVC BioPharma, Inc. (-0.83), greater than Indaptus Therapeutics, Inc. (-0.64), less than Better Therapeutics, Inc. (-0.00), greater than Forte Biosciences, Inc. (-0.86), less than PaxMedica, Inc. Common Stock (-0.04),

Build a custom stock screener for Pasithea Therapeutics Corp. (KTTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pasithea Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pasithea Therapeutics Corp. (KTTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pasithea Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.